Jan Schakowsky and U.S. Sens. Sherrod Brown and John McCain introduced H.R. 5573; the Price Relief, Innovation and Competition for Essential Drugs (PRICED) Act. As reported on congress.gov, the bill would “amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 7 years.” (The full text has not yet been uploaded.) This would allow generic firms to enter the market sooner, pulling down prices through competition.
A press release by Rep. Schakowsky notes that the legislation has been endorsed by a number of large civil society groups, including AARP, and the AFL-CIO. It also lists Rep. Jim McDermott (D-WA), Rep. Elijah Cummings (D-MD), Rep. Lloyd Doggett (D-TX), Rep. Peter Welch (D-VT), Rep. Rosa DeLauro (D-CT), and Rep. Marcy Kaptur (D-OH) as co-sponsors in the House.